• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of intravitreal bevacizumab injections to treat type 1 idiopathic macular telangiectasia.

作者信息

Moon Byung Gil, Kim Yoon Jeon, Yoon Young Hee, Lee Joo Yong

出版信息

Graefes Arch Clin Exp Ophthalmol. 2012 Nov;250(11):1697-9. doi: 10.1007/s00417-011-1798-2. Epub 2011 Aug 24.

DOI:10.1007/s00417-011-1798-2
PMID:21863255
Abstract
摘要

相似文献

1
Use of intravitreal bevacizumab injections to treat type 1 idiopathic macular telangiectasia.玻璃体内注射贝伐单抗治疗1型特发性黄斑毛细血管扩张症。
Graefes Arch Clin Exp Ophthalmol. 2012 Nov;250(11):1697-9. doi: 10.1007/s00417-011-1798-2. Epub 2011 Aug 24.
2
Intravitreal bevacizumab for perifoveal telangiectasia.玻璃体内注射贝伐单抗治疗黄斑中心凹周围毛细血管扩张症。
Acta Ophthalmol. 2011 Nov;89(7):e607-8. doi: 10.1111/j.1755-3768.2010.02007.x. Epub 2010 Oct 14.
3
Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.玻璃体内注射贝伐单抗治疗增生型和非增生型 2 型特发性黄斑毛细血管扩张症。
Retina. 2011 Oct;31(9):1848-55. doi: 10.1097/IAE.0b013e31820d3feb.
4
Long term result of intravitreal bevacizumab in a patient newly transformed to proliferative macular telangiectasia type 2.玻璃体内注射贝伐单抗治疗新转变为2型增生性黄斑毛细血管扩张症患者的长期结果
Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):360-2. doi: 10.4103/0974-9233.120005.
5
Long-term course in type 2 idiopathic macular telangiectasia.2 型特发性黄斑毛细血管扩张症的长期病程。
Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2513-20. doi: 10.1007/s00417-013-2346-z. Epub 2013 Apr 25.
6
Intravitreal bevacizumab for type 2 idiopathic macular telangiectasia.眼内注射贝伐单抗治疗 2 型特发性黄斑毛细血管扩张症。
Ophthalmic Res. 2013;49(4):205-8. doi: 10.1159/000346130. Epub 2013 Jan 29.
7
The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.玻璃体腔内注射bevacizumab 作为 Coats 病初始治疗的效果。
Graefes Arch Clin Exp Ophthalmol. 2014 Jan;252(1):35-42. doi: 10.1007/s00417-013-2409-1. Epub 2013 Jul 20.
8
Treatment of nonneovascular idiopathic macular telangiectasia type 2 with intravitreal ranibizumab: results of a phase II clinical trial.采用玻璃体内雷珠单抗治疗非新生血管性特发性黄斑毛细血管扩张症 2 型：一项 II 期临床试验结果。
Retina. 2012 May;32(5):996-1006. doi: 10.1097/IAE.0b013e31824690a8.
9
Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia.非增生型 2 型特发性黄斑毛细血管扩张症的观察、玻璃体内注射贝伐单抗与经平坦部玻璃体切除术的比较。
Graefes Arch Clin Exp Ophthalmol. 2013 Apr;251(4):1097-101. doi: 10.1007/s00417-012-2150-1. Epub 2012 Sep 6.
10
Intravitreal bevacizumab for peripapillary choroidal neovascular membranes.玻璃体内注射贝伐单抗治疗视乳头周围脉络膜新生血管膜
Arch Ophthalmol. 2012 Aug;130(8):1073-5. doi: 10.1001/archophthalmol.2012.465.

引用本文的文献

1
Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.2 型增殖性黄斑毛细血管扩张症继发视网膜下新生血管膜的不同抗血管内皮生长因子治疗后解剖和视力结果的比较。
Graefes Arch Clin Exp Ophthalmol. 2020 Jan;258(1):99-106. doi: 10.1007/s00417-019-04520-x. Epub 2019 Nov 25.
2
CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS.日本患者中未经治疗和经治疗的1型特发性黄斑毛细血管扩张症的临床特征：随访2年未发生继发性脉络膜新生血管
Retina. 2018 Jan;38 Suppl 1(Suppl 1):S114-S122. doi: 10.1097/IAE.0000000000001724.
3

本文引用的文献

1
Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.联合光动力疗法与玻璃体内注射贝伐单抗作为2型特发性黄斑毛细血管扩张症相关视网膜下新生血管形成的主要治疗方法
Indian J Ophthalmol. 2009 May-Jun;57(3):241-2. doi: 10.4103/0301-4738.49406.
2
Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT.使用光动力疗法（PDT）治疗特发性黄斑旁毛细血管扩张症中的黄斑水肿消退情况。
Ophthalmic Surg Lasers Imaging. 2009 Jan-Feb;40(1):65-7. doi: 10.3928/15428877-20090101-10.
3
Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.玻璃体内注射阿柏西普治疗1型黄斑毛细血管扩张症的疗效与眼部血管生成特征有关。
Retina. 2017 Dec;37(12):2226-2237. doi: 10.1097/IAE.0000000000001424.
4
Macular oedema related to idiopathic macular telangiectasia type 1 treated with dexamethasone intravitreal implant (ozurdex).玻璃体内注射地塞米松植入剂（Ozurdex）治疗与1型特发性黄斑毛细血管扩张相关的黄斑水肿。
Case Rep Ophthalmol Med. 2014;2014:231913. doi: 10.1155/2014/231913. Epub 2014 Jun 17.
5
Pars plana vitrectomy combined with focal endolaser photocoagulation for idiopathic macular telangiectasia.玻璃体切除术联合局部视网膜激光光凝治疗特发性黄斑毛细血管扩张症
Case Rep Med. 2014;2014:786578. doi: 10.1155/2014/786578. Epub 2014 Apr 30.
贝伐单抗（阿瓦斯汀）治疗II型特发性黄斑毛细血管扩张症
Retina. 2009 Jan;29(1):27-32. doi: 10.1097/IAE.0b013e31818ba9de.
4
Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.玻璃体内注射贝伐单抗治疗2型特发性黄斑毛细血管扩张症的18个月随访
Br J Ophthalmol. 2008 Jul;92(7):941-5. doi: 10.1136/bjo.2007.129627.
5
Bevacizumab in the treatment of idiopathic macular telangiectasia.贝伐单抗治疗特发性黄斑毛细血管扩张症
Graefes Arch Clin Exp Ophthalmol. 2008 Aug;246(8):1189-93. doi: 10.1007/s00417-008-0795-6. Epub 2008 Apr 2.
6
Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.玻璃体内注射贝伐单抗治疗2型特发性黄斑毛细血管扩张症后的荧光素血管造影和光学相干断层扫描结果
Ophthalmology. 2007 Sep;114(9):1736-42. doi: 10.1016/j.ophtha.2007.03.079.
7
Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia.
Am J Ophthalmol. 2007 Aug;144(2):296-9. doi: 10.1016/j.ajo.2007.03.059.
8
Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.玻璃体内注射贝伐单抗（阿瓦斯汀）与特发性黄斑旁视网膜毛细血管扩张症的视网膜下新生血管消退相关。
Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):1045-8. doi: 10.1007/s00417-006-0468-2. Epub 2006 Nov 29.
9
Retinal telangiectasis in adults: fluorescein angiographic findings and treatment by argon laser.成人视网膜毛细血管扩张症：荧光素血管造影结果及氩激光治疗
Br J Ophthalmol. 1978 Apr;62(4):243-50. doi: 10.1136/bjo.62.4.243.